IMM 1.72% 29.5¢ immutep limited

another good night on nasdaq, page-27

  1. 7,426 Posts.
    lightbulb Created with Sketch. 154
    And Dendron was over $40 now under $3...

    Still think that stuffed sentiment as PRR is similar technology!

    still positive sentiment in the lead up to Oct 1st...to break the long tern down trend see: charts posted.

    Like to get the full ICS data in the frame...

    Safety data to date indicate that CVac is very well tolerated as compared to observational stan- dard of care (OSC). Preliminary intracellular cytokine staining (ICS) data in three CVac treated patients have shown a potent cytotoxic T cell response specific to mucin 1, while untreated pati- ents did not show the same immune response. In the near term, upon completion of the analysis, the Company will release ICS data from a cohort of seven patients that have been followed for an extended period of time. Over the next year, Prima will have ICS data on all patients enrolled on the CAN-003 trial."

    Soure:http://www.primabiomed.com.au/announcements/pdf/2012/2012_10_15_announcement.pdf

    GLTA SHrs
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.